Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04581499 · ClinicalTrials.gov registry record · NA
Tech-Enabled CM for AUD at Scale
A NA study, sponsored by DynamiCare Health.
- Completed
- Registry status
- NA
- Development phase
- 236
- Enrollment target
NCT04581499: Completed NA study, sponsored by DynamiCare Health.
NCT04581499 is a NA study that has completed, run by DynamiCare Health. The registered enrollment target is 236 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04581499, a NA study, has completed, sponsored by DynamiCare Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 236 participants
- Enrollment target
Study Summary
This Phase II Small Business Innovative Research (SBIR) project is a clinical effectiveness and cost-effectiveness random controlled trial (RCT) of DynamiCare Health's innovative smartphone/smart debit card remote digital coaching program, which integrates Contingency Management, Recovery Coaching, and cognitive behavioral therapy (CBT), to address alcohol use disorder (AUD) in 300 adults.
Primary Outcome
The primary outcome measure is alcohol use, in terms of the number of weeks of abstinence confirmed by DynamiCare Breathalyzer tests and self-report.
Interventions
- COMBINATION_PRODUCT DynamiCare Motivation Support Program
- OTHER Untreated or Routine Care Control Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 236 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2025-06-30 |
| Phase | NA |
What the finished NCT04581499 record still lists
NCT04581499 is an interventional study that assigns participants to a tested intervention. The registered 236 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which DynamiCare Motivation Support Program is the first listed.
NCT04581499 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04581499 about?
NCT04581499 is a clinical study titled "Tech-Enabled CM for AUD at Scale". This Phase II Small Business Innovative Research (SBIR) project is a clinical effectiveness and cost-effectiveness random controlled trial (RCT) of DynamiCare Health's innovative smartphone/smart debit card remote digital coaching program, which integrates Contingency Management, Recovery Coaching, ...
What is the current status of trial NCT04581499?
This trial is currently completed. It is a NA study. The enrollment target is 236 participants. The study started on 2021-01-01. Estimated completion is 2025-06-30.
What interventions are being tested in trial NCT04581499?
The interventions under investigation include: DynamiCare Motivation Support Program (COMBINATION_PRODUCT), Untreated or Routine Care Control Group (OTHER).
Who is sponsoring clinical trial NCT04581499?
This trial is sponsored by DynamiCare Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04581499's enrollment target sits among peer trials
236 461st of 2000 higher than 1,540 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04995341 · 236 participants · NA
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
- NCT05822362 · 236 participants · Phase 2
CBD for Individuals at Risk for Alzheimer's Disease
- NCT06200103 · 236 participants · Phase 2
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
- NCT06494072 · 236 participants · Phase 4
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI